Multi-Institutional Retrospective Study for the Efficacy of ICIs plus Platinum-Based Chemotherapy for EGFR Mutated NSCLC

被引：0
|
作者：
Kataoka, S. [1 ]
Miyawaki, T. [1 ]
Motojima, M. [2 ]
Shibayama, K. [1 ]
Nanba, Y. [2 ]
Mimori, T. [1 ]
Shukuya, T. [1 ]
Shimada, N. [1 ]
Koyama, R. [3 ]
Kido, K. [3 ]
Sasaki, S. [2 ]
Takahashi, K. [1 ]
机构：
[1] Juntendo Univ, Grad Sch Med, Tokyo, Japan
[2] Juntendo Univ, Urayasu Hosp, Chiba, Japan
[3] Juntendo Univ, Nerima Hosp, Tokyo, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
EGFR mutated NSCLC; ICIs; retrospective study;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP11.03-04
引用
收藏
页码：S620 / S620
页数：1
相关论文
共 50 条
  • [41] Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort
    Prendergast, Emily N.
    Holzapfel, Marie
    Mueller, Jennifer J.
    Leitao, Mario M., Jr.
    Gunderson, Camille C.
    Moore, Kathleen N.
    Erickson, Britt K.
    Leath, Charles A., III
    Moore, Elena S. Diaz
    Cohen, Joshua G.
    Walsh, Christine S.
    GYNECOLOGIC ONCOLOGY, 2017, 144 (02) : 274 - 278
  • [42] A retrospective study on the efficacy and safety of Endostar with chemotherapy in EGFR-TKI-resistant NSCLC
    Han, Bing
    Kang, Yanrong
    Wang, Haiji
    Wang, Jian
    Shen, Rong
    Liu, Shuai
    Lu, Lu
    Sun, Zhigang
    Zhang, Nan
    BMC PULMONARY MEDICINE, 2023, 23 (01)
  • [43] A retrospective study on the efficacy and safety of Endostar with chemotherapy in EGFR-TKI-resistant NSCLC
    Bing Han
    Yanrong Kang
    Haiji Wang
    Jian Wang
    Rong Shen
    Shuai Liu
    Lu Lu
    Zhigang Sun
    Nan Zhang
    BMC Pulmonary Medicine, 23
  • [44] Prognostic factors and long-term survivors in EGFR-mutated lung cancer: A multi-institutional retrospective analysis
    Kuan, Feng-Che
    Yang, Yao Ren
    Wu Yuying
    Lin, Meng-Hung
    Shi, Chung-Sheng
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [45] Uncommon EGFR mutations in a cohort of Chinese NSCLC patients and outcomes of first-line EGFR-TKIs and platinum-based chemotherapy
    Shi, Jinpeng
    Yang, Hui
    Jiang, Tao
    Li, Xuefei
    Zhao, Chao
    Zhang, Limin
    Zhao, Sha
    Liu, Xiaozhen
    Jia, Yijun
    Wang, Yan
    Xi, Lei
    Zhang, Shijia
    Su, Chunxia
    Ren, Shengxiang
    Zhou, Caicun
    CHINESE JOURNAL OF CANCER RESEARCH, 2017, 29 (06) : 543 - +
  • [46] Phase 2 Study of Ramucirumab plus Weekly Docetaxel in Stage IV NSCLC Following Progression after Platinum-Based Chemotherapy
    Sebastian, Martin
    Ponce, Santiago
    Nikolinakos, Petros
    Varea, Rocio
    Chao, Bo
    Zimmermann, Annamaria
    Alexandris, Ekaterine
    Lee, Pablo
    Cappuzzo, Frederico
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1079 - S1080
  • [47] Genetic heterogeneity of KRAS-mutated NSCLC leads to different responses to first-line platinum-based chemotherapy
    Scheffler, M.
    Abdulla, D. S. Y.
    Koleczko, S.
    Ihle, M. A.
    Merkelbach-Bruse, S.
    Michels, S.
    Nogova, L.
    Kron, A.
    Fischer, R.
    Serke, M.
    Ko, Y. -D.
    Gerigk, U.
    Schulte, W.
    Sebastian, M.
    Riedel, R.
    Holzem, A.
    Kambartel, K. -O.
    Buettner, R.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 173 - 173
  • [48] Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
    Cho, Byeong Wook
    Kim, Seok Bae
    Song, Il Han
    Lee, Sae Hwan
    Kim, Hong Soo
    Lee, Tae Hee
    Kang, Young Woo
    Kim, Seok Hyun
    Lee, Byung Seok
    Chae, Hee Bok
    CLINICAL AND MOLECULAR HEPATOLOGY, 2017, 23 (01) : 51 - 56
  • [49] Efficacy and safety of nivolumab and irinotecan as third-line chemotherapy for advanced gastric cancer: A multi-institutional retrospective study
    Kumanishi, Ryosuke
    Mitani, Seiichiro
    Kadowaki, Shigenori
    Matsushima, Tomohiro
    Takahashi, Naoki
    Ogata, Takatsugu
    Yasui, Hisateru
    Ogata, Misato
    Satake, Hironaga
    Narita, Yukiya
    Masuishi, Toshiki
    Bando, Hideaki
    Hara, Hiroki
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [50] Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study
    Salimon, Maeva
    Prieux-Klotz, Caroline
    Tougeron, David
    Hautefeuille, Vincent
    Caulet, Morgane
    Gournay, Jerome
    Matysiak-Budnik, Tamara
    Bennouna, Jaafar
    Meyo, Manuela Tiako
    Lecomte, Thierry
    Zaanan, Aziz
    Touchefeu, Yann
    BRITISH JOURNAL OF CANCER, 2018, 118 (03) : 325 - 330
12345